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Summary Paragraph. 
 
In the past two decades a range of fluorescence cell microscopy techniques1 have been developed 
which  can achieve ~10nm spatial resolution2,3, i.e. substantially beating the usual limits set by 
optical diffraction. However, these methods rely on specialised labelling4. This limits the 
applicability, risks perturbing the biology 5,6 and it also makes them so-called “discovery techniques” 
that can only be used when there is prior knowledge about the biological  problem.  The alternative, 
electron microscopy (EM), requires complex and time-consuming sample preparation, that risks 
compromising the sample’s integrity.  Samples have to withstand vacuum, and staining with heavy 
metals to make them conductive, and give usable electron-contrast. None of these techniques can 
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directly map out drug distributions at a sub-cellular level.  Recently infrared light-based scanning 
probe techniques have demonstrated a capability for ~1nm spatial resolution 7, 8. However, they 
need samples that are flat, dry and dimensionally stable and they only probe down to a depth 
commensurate with the spatial resolution, so they yield essentially surface chemical information. 
Thus far they have been applied only to artificially produced test samples, e.g. gold particles9, or 
isolated proteins10 on silicon.  Here we show how these probe-based techniques can be adapted for 
use with routinely prepared11 general biological specimens. This allows for “Mid-infrared Chemical 
Nano-imaging” (MICHNI) that delivers chemical analysis at a ~10 nm spatial resolution, suitable for 
studying cellular ultrastructure. We demonstrate its utility by performing label-free mapping of the 
anti-cancer drug Bortezomib (BTZ) within a single human myeloma cell. We believe that this MICHNI 
technique has the potential to become a widely applicable adjunct to EM across the bio-sciences.  
  
Our MICHNI approach is based on so-called “scattering-type scanning near-field optical microscopy12 
(s-SNOM). An atomic force microscope (AFM) is used to position a sharp conducting probe to within 
a few nm of the object to be imaged, and a laser is focussed on the region where the two meet (Fig.1). 
The sharp probe tip concentrates the optical field, by a nanoscale analogue of the “lightning rod“ 
effect, to a region commensurate with its radius. An analysis of the backscattered light allows the 
optical response of the material just under the tip12 to be measured. This gives an optical image whose 
spatial resolution is determined by the tip radius, and not the light wavelength13. A spatial resolution 
of <10nm is routinely available with robust, commercially available probes. The optical image is built 
up by rastering the tip across the sample, and a standard AFM topography image is generated at the 
same time. 
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Previous s-SNOM studies have been restricted to narrow wavelength range studies of solid state 
systems. Studies include PMMA test samples14,15 , Quantum Metamaterial Superlenses16 and oxide17 
and graphene18  layers. In 
the biological realm, 
demonstrator trials have 
imaged cylindrical tobacco 
mosaic viruses deposited on 
Si 19, and dried proteins in 
lipid bilayer fragments 
extracted from bacteria and 
mounted on gold20.  
 
Mid-IR radiation in the so-
called “chemical fingerprint” spectral region (approximately 5 µm < λ < 12µm) is absorbed in localised 
bond-specific vibrational transitions that are characteristic of specific chemical moieties. The resulting 
absorption peaks are well-characterised, and have long been used, e.g. in Fourier transform infrared 
(FTIR) spectroscopy to identify and characterise (un-labelled) chemicals and to analyse mixtures21 in 
chemistry and the life sciences.  
 
If these same wavelengths are used for s-SNOM, the optical response of the region of the sample in 
the close vicinity of the tip is determined by these same bond-specific absorptions. This encodes the 
chemical mapping information into s-SNOM images12. 
 
Small-molecule drugs are exogenous species, in many cases containing chemical structures and 
functionality that give them a distinctive mid-IR “fingerprint” spectrum. This can make them stand out 
 
 
Figure 1: Schematic of the arrangement for Mid-infrared Chemical Nano-Imaging 
(MICHNI) of a sub-micron thick section of a single human myeloma cell. Light 
incident on the sharp AFM probe tip is scattered from a ~10nm region of the 
sample. This enables nanoscale intra-cellular mapping far below the diffraction 
limit (λ=9.66μm). In this plot the height corresponds to the sample topography, 
while the colour scale denotes the infrared scattering magnitude, s2. Probe and 
laser beam are not shown to scale. 
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from the normal absorption signature of biological material, and makes them particularly suitable for 
mid-IR mapping (see supplementary information).  
 
Here we show how a variant of the standard histopathological “formalin-fixed, paraffin-embedded” 
(FFPE) sample preparation method can be used to generate high-quality s-SNOM images from general 
biological material. We also show that, by adding a bank of widely tunable mid-infrared quantum 
cascade lasers (QCLs) that span the 5 µm < λ < 11µm “fingerprint” range22,23, we can perform “Mid-
infrared Chemical Nano-imaging” (MICHNI) in a way that allows us both to image chemical variations, 
and identify drug locations,  in the cellular ultrastructure.  
 
As a test example, here we have chosen to study the anti-cancer drug Bortezomib (BTZ). BTZ is a 
clinically approved agent for the treatment of multiple myeloma24, and its mechanism of action 
proceeds through inhibition of proteasomes: cellular complexes that break down proteins. In  addition 
to its clear therapeutic relevance, BTZ is particularly suitable for these experiments because it contains 
a B-C moiety which gives it a narrow vibronic absorption feature at a wavelength (1020 cm-1) where 
there is little structure in the absorption spectrum of normal human tissue (see supplementary 
information).    
Fig. 2  shows the AFM topography, and the second harmonic near-field scattered amplitude, s2 , of a 
thin (~1µm) section of a single RPMI-8226 myeloma cell, pre-treated with BTZ, fixed, dried and 
mounted on a glass microscope slide12 (see methods section). 
The AFM image (Fig. 2(a)) is essentially a height map, showing the profile of the biological material as 
it is distributed across the glass slide. It is generated mechanically, as the probe tip scans across the 
sample, like a nanoscale version of a record needle. Its lateral resolution is determined by the AFM tip 
diameter, and there is no chemical contrast. In comparison, the MICHNI image (Fig. 2 (b)) resolves a 
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host of extra sub-cellular so-called “ultrastructure” features. These include details of the cell nucleus, 
various organelles and the membrane bilayer that have not been imaged before optically.  
 
Zooming in (Fig.3 (a) and (b)) on the black dashed square of Fig. 2(b) gives a visual indication of the 
resolution enhancement of the MICHNI image (Fig.3 (b)) of over the AFM one (Fig.3 (a)). Selecting a 
fine biological feature from the ultrastructure in the MICHNI image (Fig. 3(d)) and performing a line 
scan analysis shows how the “lightning rod” effect that concentrates the laser field beneath the tip in 
the MICHNI case has resulted in a ~3x resolution improvement over AFM. The ~10 nm MICHNI 
 
Figure 2: Images of a sub-micron thick section of a single human myeloma cell mounted on a glass slide. (a) Topography, 
as measured with  an AFM and (b) near-field scattered amplitude, s2 ,measured with an s-SNOM at a wavelength of 
λ=9.8 µm (1020cm-1), where deep sub-cellular features, such as the cell nucleus and bilayer membrane, are clearly 
visible. The black dashed and green squares in (b) indicate the intra-cellular regions that are studied in more detail in 
Figs. 3 and 4, respectively. 
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resolution, corresponds to ~𝜆/1000 at the 𝜆 = 9.8μm imaging wavelength, i.e. beating diffraction by 
~3 decades, and is comparable with current EM performance. 
 
At this stage, identifying the various ultrastructure elements is complicated by the unknown amount 
of organelle shrinkage that is likely to occur during the drying stage of the sample preparation, but we 
tentatively identify oval mithochondria-like structures (white arrows, Fig. 3 (b)) which at ~ 250 nm 
long, are roughly 50% smaller than those seen in EM images of these cell lines25. Also present are a 
range of spherical vesicle-like structures with diameters in the 140nm-450nm range (blue arrows, Fig. 
3(b)).  
 
Looking ahead, we believe that specialised tissue processing protocols26 will allow the morphology 
and scale of these structures to be better preserved during sample preparation, and that this, coupled 
 
Figure3: Close-up of “ultrastructure” features in the cytoplasmic region of the cell indicated by the 3 μm x 3 μm 
black dashed square in Fig. 2(b).   Shown are the (a) AFM topography, (b) near-field second-harmonic scattered 
magnitude, s2, and (c) scattered phase, 𝜑2. Observed structures in (b) are provisionally assigned to mitochondria 
(white arrows) and vesicles (blue arrows). The pink dashed square in (b) is shown magnified in (d). The blue arrow 
in (d) indicates the direction and extent of (e) a line-scan (averaged over a width equal to width of the arrow’s 
base) of the near-field scattered amplitude, s2, (red) and AFM height (black) across a small biological feature. The 
line-scan demonstrates ~10nm resolution in the MICHNI image. 
 
7 
 
with increased practitioner experience, will enable these sub-cellular features to be visually identified 
as confidently as with EM.  
 
The frequency dependent phase of the backscattered light, 𝜑2(ν), is the key to the local chemical 
information that is contained in the optical near-field (see supplementary information). In order to 
isolate the BTZ contribution to the optical response, we first take a zero phase reference reading 
corresponding to a part of the image known to be glass (i.e. the lightest toned parts of the s2-based 
images). This datum is used to generate a false-colour 𝜑2(ν) image (Fig.3c) where the regions of 
increased optical absorption due to BTZ  cause 𝜑2(ν) to increase, and show up as red “hot spots” in 
the rendered image  (see methods section). 
 
For quantitative spectroscopic analysis, we zoom in further, to an area (Fig. 4) that corresponds the 
1.4 μm x 1.4 μm green square in Fig. 2(b). The 125 nm x 125 nm cyan square and the 250 nm x 500nm 
white dashed rectangle show the acquisition regions for the near-field signal for BTZ and glass 
substrate respectively.  Plotting the phase variation 𝜑2(ν),   with the laser tuned to the absorption 
peak of the BTZ (ν = 1020 cm-1) revealed strong concentrations of the drug in some of the vesicle-like 
structures that were visible in the AFM image. This 𝜑2(ν) phase signal almost completely vanished 
when the laser was only slightly detuned (from ν = 1020 cm-1 to ν = 1000 cm-1) away from the BTZ 
absorption peak (Fig.4(c)). 
 
An analytical treatment of the mechanism by which the tip backscatters light argues that the imaginary 
component of the scattered amplitude, Im(σ(ν)), (computed as described in the methods section) is 
proportional to the absorption coefficient of the sample in the tip region12. Fig 4(d) shows how 
Im(σ(ν)),  averaged over the 125 nm x 125 nm cyan square, varies as the QCL lasers are tuned through 
the BTZ absorption peak. The optical response signal is averaged over a ~10 nm thick patch of material, 
and corresponds to a material volume of ~10-22 m3, (~0.1 fL).  
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The  Im(σ(ν)) spectrum in Fig. 4(d) (red circles) shows good qualitative agreement with the far-field 
absorption spectrum, (black line), which was obtained with a reference sample of pure BTZ measured 
in a conventional FTIR spectrometer (see methods section) Both spectra show a sharp  peak at 
1020cm-1, with a difference in linewidth that is likely due to over-absorption in the reference sample 
whose optical thickness was not known due to the geometry of the “attenuated total reflection” 
method used. 
 
As a proteasome inhibitor, one might a priori expect the BTZ signal to peak in regions of high 
proteasome concentration in the cell. Based largely on cell-fractionation studies27, regions of 
proteasome activity and distribution are thought to typically include the outer endoplasmic reticulum, 
cytoskeleton and centrosomes, nuclei (but not nucleoli) and cytoplasm. We speculate that future 
MINCHI imaging studies will prove valuable in correlating proteasome localisation and inhibition in 
 
Figure 4: MICHNI mapping of the anti-cancer drug Bortezomib (BTZ) in a human myeloma cell. The imaged area 
is in the cell cytoplasm and corresponds to the 1.4 μm x 1.4 μm green square in Fig.2 (b). (a) The AFM 
topography of the magnified region. The cyan square and white dashed rectangle show the averaging areas for 
acquisition of BTZ and glass near-field signals, respectively. The patch of BTZ measured is ~9nm thick with 
radius ~60nm. The near-field phase images, 𝜑2, at 1020cm-1 (b) and 1000cm-1 (c) have been referenced to the 
zero phase signal from the glass substrate. (d) Comparison of the normalised imaginary component of the near-
field signal, Im(σ), (orange circles) and the far-field absorption  spectrum(black line) taken  from a separate FTIR 
spectral measurement of bulk BTZ. Error bars correspond to the standard error of the mean values within the 
respective averaging regions. 
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different cell types and under different conditions, thereby informing on the sensitivity of proteasome 
inhibition in certain disease states (i.e. multiple myeloma). 
 
In conclusion, we have demonstrated MICHNI imaging of single cells for the first time, with a spatial 
resolution that already rivals EM and can probably be extended down to the ~1nm level with sharper 
tips7,8. The sample preparation protocol is simpler than for EM, and it preserves the sample chemistry 
and structure. The contrast mechanism is sufficiently well understood that quantitative information 
can be extracted from the MICHNI images and we have used this to map the distribution and localise 
the binding sites of an important drug within a single cell for the first time. 
 
These findings promise a new route to studying intra-cellular chemical processes in a way that does 
not unintentionally influence them with artificial labelling. We believe that the MICHNI technique on 
its own has the potential for widespread applications across the fields of cancer, cellular pathology in 
general, and drug discovery. In addition, it could offer useful correlative morphological and chemical 
information for research problems that are currently being studied by EM. 
 
 
Methods 
 
Spectroscopic Mid-Infrared CHemical Nano-Imaging (MICHNI). 
 
 
The MICHNI images presented in this study were generated using ~100mW level tuneable (~900-
1900cm-1) mid-infrared laser light generated by a switchable bank of commercial quantum cascade 
lasers (MIRcat, Daylight Solutions). This beam was focussed to the tip of a Pt/Ir-coated Silicon AFM 
probe (Arrow-NCPt, Nanoworld) in a commercial s-SNOM (NeaSNOM, Neaspec). The probe tip has a 
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radius ~10nm, which acts to greatly enhance the scattering of the optical near-field in the region 
immediately beneath its apex12. The AFM component of the system was set to give a mean probe 
height of ~50 nm above the sample, and it was oscillating vertically with an amplitude of ~50nm at its 
mechanical resonance frequency 𝜔 ≈ 280 kHz.  
 
The IR light backscattered from the tip was detected by a LN2 cooled HgCdTe detector. The amount of 
scattered near-field optical signal depends on the tip-sample separation in a highly non-linear fashion, 
and this generates components at harmonics (nω) of the tip vibration frequency in the power 
spectrum of the backscattered light. Analysis of the “approach curves” 13 implies that, in general the 
higher the harmonics contain a larger proportion of the optical near-field information, and should 
therefore give the best spatial resolution, with the lowest background component. However, there is 
a signal-to-noise trade-off because the harmonic optical power decreases with n. Signals demodulated 
at the n = 2 harmonic were used in this study. To further decouple near-field from far-field, a 
pseudoheterodyne interferometric detection scheme was employed28. 
 
A full numerical analysis of the interaction between the laser radiation and the oscillating tip is beyond 
the scope of this paper. However, the fact that, in solid samples, damping broadens the IR absorption 
peaks means that typically the material dispersion is weak. This allows for an analytical model of the 
tip-sample interaction, (where the spherical tip is modelled as a point dipole) which, in turn, predicts 
that, the optical phase of the backscattered signal is proportional to the absorption coefficient of the 
material beneath the tip 15,19,20, 29.   
 
Even if this “weakly dispersive” approximation is not reliable, given that the technique works with 
optical processes that are linear and therefore obey the principle of superposition, reliable 
concentration estimates can be obtained by measuring reference scattering phase values with the 
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bare substrate, and subsequently recording the degree of phase shift as the tip is rastered over the 
bio-material 19,20. 
 
To analyse the MICHNI images, the spectroscopic signature of the BTZ was isolated by first acquiring 
a frequency dependent reference phase value, 𝜑𝑔𝑙𝑎𝑠𝑠(𝜈), with the probe imaging a part of the glass 
substrate close to the ultrastructure component of interest. This allowed the degree of phase shift 
corresponding to the BTZ absorption to be computed as (𝜑(𝜈) = 𝜑𝐵𝑇𝑍(𝜈) − 𝜑𝑔𝑙𝑎𝑠𝑠(𝜈)). The 
backscattered amplitude was then normalised to that of the glass, (𝑠(𝜈) = 𝑠𝐵𝑇𝑍(𝜈)/𝑠𝑔𝑙𝑎𝑠𝑠(𝜈)). This 
allowed the imaginary component of the backscattered signal, 𝐼𝑚(𝜎) to be computed as 𝐼𝑚(𝜎) =
𝑠 sin(𝜑).  
 
Here 𝐼𝑚(𝜎) is the imaginary component of the complex near-field scattering coefficient, which is itself 
proportional to the absorption coefficient of the material beneath the tip. For the BTZ experiments, 
the𝐼𝑚(𝜎) signal showed the pronounced spectral resonance at 1020 cm-1 shown in Fig.4 (d)).  
 
Unfortunately, at the time of writing, this quantitative analysis cannot be performed in e.g. the depths 
of the cell nucleus because of difficulties in accounting for phase uncertainties caused by the large 
height variations across the nucleus.  
 
 
Far-field infrared absorption spectroscopy. 
 
A pure sample of BTZ was acquired from Selleckchem at 99.94% purity (catalogue number S1013, 
batch number S101315). A commercial FTIR spectrometer (Frontier FT-IR/MIR, PerkinElmer) equipped 
with a KBr window, a ATR (attenuated total reflectance) accessory and a LiTaO3 detector was used to 
record the IR spectrum in the 4000-650 cm-1 range, at 4 cm-1 resolution and with a scan speed of 0.2 
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cm sec-1). Approximately, 2 mg of solid BTZ was applied over the exposed KBr ATR crystal surface using 
a carefully cleaned sample mounting plate. The knob of the pressure arm was then swung over the 
sample and knob was rotated to apply pressure. Finally, the ATR spectrum of BTZ was recorded and 
normalised against a background air spectrum (see supporting information). 
 
Cell preparation. 
 
All the studies were performed using RPMI-8226 myeloma cells, cultured in RPMI-1640 medium. The 
medium was supplemented with 10% FCS, penicillin (100U/ml), 5% glutamine, and streptomycin 
sulphate (100μg/ml). Cells were cultured at 37°C in a humidified atmosphere containing 5% CO2. Cells 
were harvested, washed twice with PBS, and counted prior to BTZ treatment. 1x107 cells were 
incubated with 8µM of BTZ in vehicle (0.1% DMSO) for 1h at 37°C. Cells were washed twice in PBS 
before being pelleted for paraffin embedding and sectioning. 
 
Pellets of washed RPMI-8226 myeloma cells were fixed in 4% paraformaldehyde for 30min at room 
temperature. These were processed for embedding in paraffin as per published protocol11. Cell blocks 
were cut into ~1µm sections using a microtome before being mounted onto glass slides. To ensure 
the sections adhered well, the glass slides were heated to 60°C for 10min before 5min of cooling at 
room temperature. The mounted samples were dewaxed by being immersed in a series of two xylene, 
followed by three ethanol baths, each for 5min. 
 
This sample preparation process is the formalin-fixed-paraffin-embedded (FFPE) “gold standard” 
protocol11 that is used to make many tens of thousands of biopsy sections in hospital pathology 
laboratories for routine haematoxylin and eosin (“H+E”) based disease diagnoses annually.  
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The principle modifications were to use a thinner section (estimated to be ~1µm thick before 
dewaxing,) so that the sample height fluctuations were kept within the allowable range of the AFM, 
and omitting the H+E staining and protection stages of the sample preparation protocol altogether. 
 
The MICHNI images are all taken at ambient pressure and temperature, and the cells are unstained 
and unlabelled throughout.  
 
At present the specimens are imaged while they are dry, so whilst the chemical information is well 
preserved, the details of the ultrastructural morphology will be influenced by shrinkage rates that may 
vary between the different ultrastructure components. This makes it difficult to be confident when 
comparing MICHNI images with those in the EM-based literature.  
 
Looking ahead, we expect that a combination of operator experience, coupled with correlation studies 
and developments on fixing protocols will surmount this obstacle.  
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Supplementary information  
 
Comparison of Bortezomib and Human tissue infrared spectra 
 
Bortezomib (BTZ) is a promising candidate for spectroscopic mapping, as it has an unusual chemical 
structure, containing boron, and an associated B-C bond (Fig. S1(a)), which is rarely found in nature. 
This yields a strong, sharp absorption resonance in a spectral region where the absorption spectrum 
of biological material is normally featureless (Fig. S1(b)). 
 
Figure S1: (a) The unusual chemical structure of Bortezomib (BTZ) results in (b) an infrared far-field absorption spectrum 
(blue) that is highly distinctive compared with typical human tissue (red; reproduced with permission from [30]). 
  
The relative contributions of the near-field amplitude and phase to spectral changes in Im(σ). 
 
Strictly speaking, it is the imaginary component of the near-field scattering that is proportional to 
local absorption12, however it is often the case that the majority of the chemical contrast signal in 
the imaginary component spectrum comes from the contribution of the near-field phase variation. 
This is clearly shown in Fig. S2, whereby the amplitude spectrum is relatively flat compared with the 
phase spectrum. Comparing these figures with Fig. 4(d) of the main text, it is clear that the phase 
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and imaginary spectra are in good agreement.
 
Figure S2: (a) Near-field amplitude and (b) phase spectra of Bortezomib in a cell (as shown in Fig. 4.) 
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